Toxicity of Bevacizumab in Combination with Chemotherapy in Older Patients

BACKGROUND. Bevacizumab leads to improved survival for patients with metastatic colorectal cancer (CRC) or non-small cell lung cancer (NSCLC) when added to chemotherapy. Little is known about factors associated with receipt of bevacizumab, or whether bevacizamab is associated with increased toxicity...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Mohile, Supriya G., Hardt, Molly, Tew, William, Owusu, Cynthia, Klepin, Heidi, Gross, Cary, Gajra, Ajeet, Lichtman, Stuart M., Feng, Tao, Togawa, Kayo, Ramani, Rupal, Katheria, Vani, Hansen, Kurt, Hurria, Arti
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2013
Assuntos:
Geriatric Oncology
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3639527/
https://ncbi.nlm.nih.gov/pubmed/23576485
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2012-0351
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados